Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients

NCT00171496 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

693

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplant

Interventions

DRUG: Cyclosporine microemulsion
DRUG: Tacrolimus

Sponsor

Novartis